Ranbaxy signs agreement with CD Pharma for 'Inersan' pills
New Delhi, Mar 18 (UNI) Pharmaceutical major Ranbaxy Laboratories Ltd today said it has signed an exclusive in-licensing agreement with CD Pharma to market Inersan tablets, used for the treatment of dental problems, in the country along with Nepal.
Inersan, first of its kind natural biological patented product to be introduced in the country, will be used to treat dental problems such as Periodontitis, Gingivitis and Halitosis, a statement said.
At present, there is no particular drug available for the treatment of these dental problems, which can affect a person's overall health.
UNI SG SBA SSC1338
More From
-
Bangalore Gold Silver Rate Today, March 9, 2026: Gold and Silver Prices Fall as US Dollar Strengthens -
Vijay-NDA Alliance On Cards? Pawan Kalyan Reportedly Reaches Out to TVK Chief -
Who Was Mojtaba Khamenei’s Wife Zahra Haddad-Adel and What Do We Know About Her? -
Who Is Aditi Hundia? Viral ‘Girl in Red’ & Ishan Kishan's Girlfriend Spotted During IND vs NZ Final -
Hyderabad Gold Silver Rate Today, 9 March 2026: Latest 24K, 22K Gold And Silver Rates In City -
Kerala Election 2026 Date: When Can You Expect EC To Announce Key Dates of Voting & Counting? -
Chennai MRTS Velachery–St Thomas Mount Line Opening on March 10 Faces Delay; Direct Beach Route to Start Later -
Mumbai Water Supply Cut For 24 Hours: Check Dates, Timings & Areas Affected by BMC Maintenance Disruption -
Hardik Pandya and Girlfriend Mahieka Sharma’s Celebration Video Goes Viral After India’s Win -
Bengaluru Hotels to Shut From Tomorrow March 10 as Commercial LPG Supply Stops -
Trisha's Net Worth: How Rich Is Thalapathy Vijay's Rumoured Girlfriend? -
Pune Electrician Arrested After Viral Video Shows Him Raising ‘Pakistan Zindabad’ Slogans, Watch
Click it and Unblock the Notifications
Sign in with Google